Pharma & Healthcare Technology


Pharma and Healthcare Technology Market Research Reports Analysis and Trends

 

Publication Single User License (PDF) Price
Cancer Vaccine Partnering Terms and Agreements

Cancer Vaccine Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Vaccine Partnering Agreements Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Vaccine Partnering Agreements report provides an understanding and access to the cancer vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Cancer Diagnostics Partnering Terms and Agreements

Cancer Diagnostics Partnering Terms and Agreements

Date Published: Dec 1 2014

The Cancer Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Cancer Diagnostics Partnering Agreements report provides an understanding and access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.

$2,995.00
Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies.

Description
The Royalty Financing Terms and Agreements in Pharma, Biotech and Diagnostics report provides detailed understanding and analysis of how and why companies enter royalty financing deals.

$1,995.00
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

$2,995.00
Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics

Date Published: Dec 1 2014

The Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the manufacturing and supply agreements entered into by the world’s biopharma companies

$3,295.00
Gene Therapy Partnering Terms and Agreements

Gene Therapy Partnering Terms and Agreements

Date Published: Dec 1 2014

The Gene Therapy Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
The Gene Therapy Partnering Agreements report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.

$1,995.00
Analysing the Telemedicine Market in India

Analysing the Telemedicine Market in India

Date Published: Nov 23 2014

The telemedicine market in India has witnessed significant growth, owing to its potential of providing the world class clinical and medical services to distant and rural locations. The industry has garnered the support of both the government and private organizations that are investing in telemedicine to make healthcare accessible across India.

$500.00
Indian Coronary Stent Market Forecast to 2019

Indian Coronary Stent Market Forecast to 2019

Date Published: Nov 18 2014
Heart diseases are on the rise in India. It is estimated that 10 percent of urban adult population and 5 percent of rural adult population suffer from some form of heart diseases and 20-30 percent of them require specialized investigation and treatment to prevent deaths due to heart ailments and coronary vascular diseases (CVD).
 
$1,200.00
Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018

Interventional Cardiology (Devices & Technology) - Global Trends, Estimates and Forecasts, 2012-2018

Date Published: Nov 3 2014
Global Interventional Cardiology market is estimated to reach US$22.2 billion by 2016. Global Interventional Cardiac Devices Industry market is worth US$20.6 billion by 2016, growing at a CAGR of 9.2% for the analysis period 2012-2018 respectively. North American region accounts for highest percentage approximately 35.8% (2015) of global share while Europe follows next with nearly 28.8% (2018) of the market. Asia-Pacific is the fastest growing region with a CAGR of 11.6% driving a market value of US$4.7 billion by 2015.
$4,450.00
Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Interventional Cardiology (Devices & Technology) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Date Published: Nov 3 2014
BRICSS Interventional Cardiology Devices sector is projected to reach at US$3.3 billion by 2016. China accounts for highest percentage approximately 28% (2015) of global share while India follows next with nearly 25% (2018) of the market. Forecasts for Cardiac Catheters indicate a close 50%, while Arteriotomy Closure Devices accounts for nearly 6% of the market share.
$3,100.00
Stada Partnering 2009-2014

Stada Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Stada and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Stada report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Stada and its partnering interests and activities over the past five years.

$995.00
Allergy Partnering 2009-2014

Allergy Partnering 2009-2014

Date Published: Nov 1 2014

The Allergy Partnering 2009-2014 report provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies

Description
The Allergy Partnering 2009-2014 report provides understanding and access to the allergy partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in allergy partnering deals
Top allergy deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

$995.00
Daiichi Sankyo Partnering 2009-2014

Daiichi Sankyo Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Daiichi Sankyo and its partnering interests and activities over the past seven years.

Description
This report provides all the information you require to better understand Daiichi Sankyo and its partnering interests and activities over the past seven years.

$995.00
Ovarian Cancer Partnering 2009-2014

Ovarian Cancer Partnering 2009-2014

Date Published: Nov 1 2014

The Ovarian Cancer Partnering 2009-2014 report provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in ovarian cancer partnering deals
Top ovarian cancer deals by value
Deals listed by company A-Z, industry sector, stage of development, technology type

Description
The Ovarian Cancer Partnering 2009-2014 provides understanding and access to the ovarian cancer partnering deals and agreements entered into by the worlds leading healthcare companies.

$995.00
Age-related Macular Degeneration Partnering 2009-2014

Age-related Macular Degeneration Partnering 2009-2014

Date Published: Nov 1 2014

Age-related Macular Degeneration Partnering 2009-2014 report provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

Description
Age-related Macular Degeneration Partnering 2009-2014 report provides understanding and access to the age-related macular degeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

$695.00
Medivation Partnering 2009-2014

Medivation Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Medivation and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Medivation 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Medivation and its partnering interests and activities over the past seven years.

$995.00
Cosmetics Partnering 2009-2014

Cosmetics Partnering 2009-2014

Date Published: Nov 1 2014

Cosmetics Partnering 2009-2014 report provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies

Description
Cosmetics Partnering 2009-2014 report provides understanding and access to the cosmetics partnering deals and agreements entered into by the worlds leading healthcare companies.

•Trends in cosmetics partnering deals
•Top cosmetics deals by value
•Deals listed by company A-Z, industry sector, stage of development, technology type

$995.00
Alexion Pharmaceuticals Partnering 2009-2014

Alexion Pharmaceuticals Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Alexion Pharmaceuticals and its partnering interests and activities over the past seven years

Description
The Partnering Agreements with Alexion Pharmaceuticals 2009-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Alexion Pharmaceuticals and its partnering interests and activities over the past seven years.

$995.00
Astellas Partnering 2009-2014

Astellas Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Astellas and its partnering interests and activities over the past seven years

Description
This report provides all the information you require to better understand Astellas and its partnering interests and activities over the past seven years.

$995.00
Vertex Partnering 2009-2014

Vertex Partnering 2009-2014

Date Published: Nov 1 2014

This report provides all the information you require to better understand Vertex and its partnering interests and activities over the past seven years.

Description
The Partnering Agreements with Vertex 2009-2014 report provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.

This report provides all the information you require to better understand Vertex and its partnering interests and activities over the past seven years.

$995.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data